Instem Chief Scientific Officer Conducting Pistoia Alliance Panel Discussion
Industry Leaders to Discuss Genomics and Impacts to New Modes of Healthcare
CONSHOHOCKEN, PA – December 1, 2014 - - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that Gordon Baxter, CSO at Instem, will be moderating a Pistoia Alliance debate Webcast entitled, “Genomics, Pharmaceutical R&D Healthcare: Are we there yet?”
As various genomics initiatives have promised to revolutionize healthcare for over 20 years, it is important to ask whether these have had the impact they were expected to make, and how we might take greater advantage of the technology available.
Gordon Baxter will chair a panel comprised of experts in the field including Abel Ureta-Vidal, CEO at Eagle Genomics, Fiona Nielsen, CEO at DNA Digest, Dan Housman, Director at ConvergeHealth by Deloitte, and Etzard Stolte, former CIO of the Jackson Laboratory.
The Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D, is hosting a ‘Pistoia Alliance Debates’ webinar which will look at whether the economic, technical and regulatory barriers have been addressed, and how to overcome any that may remain.
As well as exploring the remaining obstacles to greater adoption of genomics technology in healthcare, the panel will look at the success of recent genomics initiatives, the impact they have had, and will consider what future genomic innovation may bring to the industry. Following the discussion, webinar attendees will be able to ask questions of the panel.
Gordon Baxter, Instem’s CSO, joined the Pistoia board in September 2013 and, leveraging his experience in R&D ontology, regulatory data exchange standards and clinical informatics, has been sharply focused on bringing data together from research, development and medical practice to generate new scientific insight.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600